Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

The Food and Drug Administration (FDA) has approved the safety labeling changes of the heartburn and gastroparesis medication Reglan (metoclopramide) which includes a black box warning of a serious and often irreversible movement disorder called Tardive Dyskinesia. The warning includes Reglan (metoclopramide) tablets, ODT (orally disintegrating tablets), and injection.

Read the rest of this entry »

Karter’s parents want to know if their infant son has Tardive Dyskinesia (TD). The little guy thrusts his body around and cries constantly for several minutes as his family watches helplessly. They posted this video, called Is this Tardive Dyskinesia, just four weeks ago on YouTube seeking answers.

Read the rest of this entry »